The Department of Health says experts are assessing how the AstraZeneca vaccine doses will be used effectively in the future. This comes after the government placed a temporary halt in the rollout of the shot. Studies have indicated that the vaccine has 22% efficacy in preventing mild to moderate cases of the COVID-19 501Y.V2 variant in South Africa. This is what is wrong with AstraZeneca:  